
WASHINGTON, May 20 (Reuters) - The U.S. Supreme Court on Monday agreed to hear a patent dispute concerning Medtronic Inc over medical devices it manufactures that give the heart electrical jolts when it fails to pump blood properly.
WASHINGTON, May 20 (Reuters) - The U.S. Supreme Court on Monday agreed to hear a patent dispute concerning Medtronic Inc over medical devices it manufactures that give the heart electrical jolts when it fails to pump blood properly.
vulnerable if larger competitors like Medtronic and Roche produce similar or superior ..... a steady stream of innovation. Medtronic remains the leader in pioneering ..... However, we'll keep a close eye on Medtronic 's potential launch of a competitive
By Peter Geschek : At this point an artificial pancreas is only a concept rather than a clinical reality. A small implantable device, an artificial pancreas would continuously monitor blood-sugar levels and release insulin as needed in patients with Type 1 diabetics. It would do everything the real
Medtronic ( MDT ) says data presented at the Heart Rhythm Society's 34th Annual Scientific ..... Lead Integrity Alert software detected pace/sense lead issues in non- MDT leads at a greater rate than standard impedance monitoring alone. The analysis
The procedure is promising to become a major income source for device makers. Front runners in the technology are Medtronic ( MDT ) and St Jude Medical ( STJ ). It is approved in Europe but experimental in the US. Resistant hypertension Treatment
North Carolina, and the Cleveland Clinic in Ohio perform the initial implants of a novel stent graft system from Medtronic ( MDT +1% ) as part of an FDA initiative designed to encourage more early-stage clinical research on new medical devices
valve and renal denervation markets will follow that of Medtronic MDT and St. Jude STJ--underscoring Boston's narrow ..... opening to Boston to press its advantage, we suspect Medtronic has outpaced Boston in stealing share. The window of
much larger competitors, such as Medtronic and St. Jude Medical. Deep-pocketed ..... even after the entrance of rival Medtronic , practitioners and payers may opt ..... this side effect, especially as Medtronic and St. Jude pursue their own valves
April 23 (Reuters) - Edwards Lifesciences Corp said on Tuesday first-quarter net earnings more than doubled, boosted by a large gain from patent litigation with Medtronic Inc , but the heart valve maker lowered its 2013 outlook due to sluggish sales at the start of the year.